Abstract
Purpose
As cardiovascular implantable electronic devices (CIEDs) are increasingly indicated in older patients, and the burden of cancer is rising with the aging population, the management of patients with CIEDs who require radiotherapy (RT) is a timely concern. The objective of the study was to evaluate the management of, and malfunctions in, patients with CIEDs undergoing RT.
Methods
A retrospective study of patients with CIEDs receiving RT at Kingston Health Sciences Center from March 2007–April 2018 was conducted. Data on demographics, RT, devices, and management were compared for the primary outcome of device malfunction.
Results
Of the 189 patients with CIEDs receiving a total of 297 courses of RT, 4 patients (2.1%) experienced device malfunctions. Higher beam energy was associated with a malfunction (p < 0.05). Patients with malfunctions received a lower dose of radiation per fraction (267 ± 93 cGy vs. 477 ± 282 cGy; p < 0.05) and were significantly younger (71.4 ± 2.2 years vs. 77.8 ± 9.8 years; p < 0.01) compared to patients without malfunctions.
Conclusion
RT-induced device malfunctions are rare, but given the potential complications, a better understanding of the potential predictors of malfunction and the development of evidence-based guidelines will help optimize patient safety.
Similar content being viewed by others
References
Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol. 2011;34(8):1013–27.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
Yeung C, Chacko S, Glover B, Campbell D, Crystal E, Ben-Dov N, et al. Radiotherapy for patients with cardiovascular implantable electronic devices: a review. Can J Cardiol. 2018;34(3):244–51.
Solan AN, Solan MJ, Bednarz G, Goodkin MB. Treatment of patients with cardiac pacemakers and implantable cardioverter-defibrillators during radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59(3):897–904.
Sabater S, Montero A, Lopez Fernandez T, Gonzalez Ferrer JJ, Arenas M. Management of patients with implanted cardiac devices during radiotherapy: results of a Spanish survey in radiation oncology departments. Clin Transl Oncol. 2018.
Wadasadawala T, Pandey A, Agarwal JP, Jalali R, Laskar SG, Chowdhary S, et al. Radiation therapy with implanted cardiac pacemaker devices: a clinical and dosimetric analysis of patients and proposed precautions. Clin Oncol (R Coll Radiol). 2011;23(2):79–85.
Gauter-Fleckenstein B, Israel CW, Dorenkamp M, Dunst J, Roser M, Schimpf R, et al. DEGRO/DGK guideline for radiotherapy in patients with cardiac implantable electronic devices. Strahlenther Onkol. 2015;191(5):393–404.
Tseng ZH. Risk of cardiovascular implantable electronic device malfunction with radiation therapy: location, dose, or energy? JAMA Intern Med. 2015;175(10):1698–9.
Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, Birgersdotter-Green U, Clarke GD, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices. Heart Rhythm. 2017;14(7):e97–e153.
Gossman MS, Wilkinson JD, Mallick A. Treatment approach, delivery, and follow-up evaluation for cardiac rhythm disease management patients receiving radiation therapy: retrospective physician surveys including chart reviews at numerous centers. Med Dosim. 2014;39(4):320–4.
Zaremba T, Jakobsen AR, Sogaard M, Thogersen AM, Riahi S. Radiotherapy in patients with pacemakers and implantable cardioverter defibrillators: a literature review. Europace. 2016;18(4):479–91.
Grant JD, Jensen GL, Tang C, Pollard JM, Kry SF, Krishnan S, et al. Radiotherapy-induced malfunction in contemporary cardiovascular implantable electronic devices: clinical incidence and predictors. JAMA Oncol. 2015;1(5):624–32.
Makkar A, Prisciandaro J, Agarwal S, Lusk M, Horwood L, Moran J, et al. Effect of radiation therapy on permanent pacemaker and implantable cardioverter-defibrillator function. Heart Rhythm. 2012;9(12):1964–8.
Zaremba T, Jakobsen AR, Sogaard M, Thogersen AM, Johansen MB, Madsen LB, et al. Risk of device malfunction in cancer patients with implantable cardiac device undergoing radiotherapy: a population-based cohort study. Pacing Clin Electrophysiol. 2015;38(3):343–56.
Zaremba T, Jakobsen AR, Thogersen AM, Oddershede L, Riahi S. The effect of radiotherapy beam energy on modern cardiac devices: an in vitro study. Europace. 2014;16(4):612–6.
Mouton J, Haug R, Bridier A, Dodinot B, Eschwege F. Influence of high-energy photon beam irradiation on pacemaker operation. Phys Med Biol. 2002;47(16):2879–93.
Hurkmans CW, Scheepers E, Springorum BG, Uiterwaal H. Influence of radiotherapy on the latest generation of pacemakers. Radiother Oncol. 2005;76(1):93–8.
Hurkmans CW, Scheepers E, Springorum BG, Uiterwaal H. Influence of radiotherapy on the latest generation of implantable cardioverter-defibrillators. Int J Radiat Oncol Biol Phys. 2005;63(1):282–9.
Brambatti M, Mathew R, Strang B, Dean J, Goyal A, Hayward JE, et al. Management of patients with implantable cardioverter-defibrillators and pacemakers who require radiation therapy. Heart Rhythm. 2015;12(10):2148–54.
Munshi A, Wadasadawala T, Sharma PK, Sharma D, Budrukkar A, Jalali R, et al. Radiation therapy planning of a breast cancer patient with in situ pacemaker--challenges and lessons. Acta Oncol. 2008;47(2):255–60.
Hurkmans CW, Knegjens JL, Oei BS, Maas AJ, Uiterwaal GJ, van der Borden AJ, et al. Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in the Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO). Radiat Oncol. 2012;7:198.
Salerno F, Gomellini S, Caruso C, Barbara R, Musio D, Coppi T, et al. Management of radiation therapy patients with cardiac defibrillator or pacemaker. Radiol Med. 2016;121(6):515–20.
Ferrara T, Baiotto B, Malinverni G, Caria N, Garibaldi E, Barboni G, et al. Irradiation of pacemakers and cardio-defibrillators in patients submitted to radiotherapy: a clinical experience. Tumori. 2010;96(1):76–83.
Gomez DR, Poenisch F, Pinnix CC, Sheu T, Chang JY, Memon N, et al. Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. Int J Radiat Oncol Biol Phys. 2013;87(3):570–5.
Langer M, Orlandi E, Carrara M, Previtali P, Haeusler EA. Management of patients with implantable cardioverter defibrillator needing radiation therapy for cancer. Br J Anaesth. 2012;108(5):881–2 author reply 2.
Sung W, Kim S, Kim JI, Lee JG, Shin YJ, Jung JY, et al. Dosimetric perturbations due to an implanted cardiac pacemaker in MammoSite((R)) treatment. Med Phys. 2012;39(10):6185–91.
Peet SC, Wilks R, Kairn T, Crowe SB. Measuring dose from radiotherapy treatments in the vicinity of a cardiac pacemaker. Phys Med. 2016;32(12):1529–36.
Munshi A, Agarwal JP, Pandey KC. Cancer patients with cardiac pacemakers needing radiation treatment: a systematic review. J Cancer Res Ther. 2013;9(2):193–8.
Sundar S, Symonds RP, Deehan C. Radiotherapy to patients with artificial cardiac pacemakers. Cancer Treat Rev. 2005;31(6):474–86.
Tajstra M, Gadula-Gacek E, Buchta P, Blamek S, Gasior M, Kosiuk J. Effect of therapeutic ionizing radiation on implantable electronic devices: systematic review and practical guidance. J Cardiovasc Electrophysiol. 2016;27(10):1247–51.
Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) expert consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Heart Rhythm. 2011;8(7):1114–54.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Additional information
What’s New?
● Although radiotherapy (RT)-induced device malfunctions are rare, there are no universal evidence-based guidelines for the management of patients with cardiovascular implantable electronic devices (CIEDs) undergoing RT, and considerable variation exists in clinical practice.
● There has been no published literature detailing a formal workflow for the interdisciplinary management of patients with CIEDs requiring RT.
● This manuscript will describe a standardized protocol for the communication and collaboration between the radiation oncology and cardiology departments for the purposes of (i) ensuring patients with CIEDs are safely treated when they require RT, and (ii) minimizing the risk of CIED failure when RT is given; and evaluate the data from the 11-year experience regarding the recommendations and device malfunctions.
Electronic supplementary material
ESM 1
(PDF 575 kb)
Rights and permissions
About this article
Cite this article
Yeung, C., Hazim, B., Campbell, D. et al. Radiotherapy for patients with cardiovascular implantable electronic devices: an 11-year experience. J Interv Card Electrophysiol 55, 333–341 (2019). https://doi.org/10.1007/s10840-018-0506-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-018-0506-0